[go: up one dir, main page]

SE0202673D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
SE0202673D0
SE0202673D0 SE0202673A SE0202673A SE0202673D0 SE 0202673 D0 SE0202673 D0 SE 0202673D0 SE 0202673 A SE0202673 A SE 0202673A SE 0202673 A SE0202673 A SE 0202673A SE 0202673 D0 SE0202673 D0 SE 0202673D0
Authority
SE
Sweden
Prior art keywords
bond
optionally substituted
chemical compounds
making
provides
Prior art date
Application number
SE0202673A
Other languages
English (en)
Inventor
Lilian Alcaraz
Mark Furber
Mark Purdie
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0202673A priority Critical patent/SE0202673D0/sv
Publication of SE0202673D0 publication Critical patent/SE0202673D0/sv
Priority to TW092102511A priority patent/TW200303304A/zh
Priority to SG200605606-3A priority patent/SG149695A1/en
Priority to MXPA04007906A priority patent/MXPA04007906A/es
Priority to CNB038041308A priority patent/CN100352807C/zh
Priority to RU2004122114/04A priority patent/RU2330019C2/ru
Priority to CA002472822A priority patent/CA2472822A1/en
Priority to NZ541682A priority patent/NZ541682A/en
Priority to UA20040705865A priority patent/UA80268C2/uk
Priority to AT03705600T priority patent/ATE480518T1/de
Priority to PCT/SE2003/000258 priority patent/WO2003068743A1/en
Priority to KR10-2004-7012756A priority patent/KR20040084920A/ko
Priority to US10/504,936 priority patent/US7709500B2/en
Priority to BR0307477-3A priority patent/BR0307477A/pt
Priority to AU2003206554A priority patent/AU2003206554B2/en
Priority to EP03705600A priority patent/EP1478624B1/en
Priority to JP2003567874A priority patent/JP4435571B2/ja
Priority to DE60334074T priority patent/DE60334074D1/de
Priority to NZ534296A priority patent/NZ534296A/en
Priority to PL03372538A priority patent/PL372538A1/xx
Priority to ARP030100530A priority patent/AR038566A1/es
Priority to IS7381A priority patent/IS7381A/is
Priority to CO04078830A priority patent/CO5611135A2/es
Priority to NO20043899A priority patent/NO20043899L/no
Priority to RU2007146928/04A priority patent/RU2007146928A/ru
Priority to IL195011A priority patent/IL195011A0/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE0202673A 2002-02-18 2002-09-09 Chemical compounds SE0202673D0 (sv)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE0202673A SE0202673D0 (sv) 2002-09-09 2002-09-09 Chemical compounds
TW092102511A TW200303304A (en) 2002-02-18 2003-02-07 Chemical compounds
PL03372538A PL372538A1 (en) 2002-02-18 2003-02-17 Chemical compounds
US10/504,936 US7709500B2 (en) 2002-02-18 2003-02-17 Chemical compounds
BR0307477-3A BR0307477A (pt) 2002-02-18 2003-02-17 Compostos quìmicos
CNB038041308A CN100352807C (zh) 2002-02-18 2003-02-17 被取代的哌啶化合物
RU2004122114/04A RU2330019C2 (ru) 2002-02-18 2003-02-17 Производные пиперидина, способ их получения, фармацевтическая композиция на их основе и способ лечения хемокин-опосредованного болезненного состояния с их использованием
CA002472822A CA2472822A1 (en) 2002-02-18 2003-02-17 Chemical compounds
NZ541682A NZ541682A (en) 2002-02-18 2003-02-17 Chemical compounds
UA20040705865A UA80268C2 (en) 2002-09-09 2003-02-17 Piperidine derivatives, process for the preparation thereof, pharmaceutical composition based thereon and method for treatment chemokine mediated disease
AT03705600T ATE480518T1 (de) 2002-02-18 2003-02-17 Chemische verbindung
PCT/SE2003/000258 WO2003068743A1 (en) 2002-02-18 2003-02-17 Chemical compounds
KR10-2004-7012756A KR20040084920A (ko) 2002-02-18 2003-02-17 화합물
SG200605606-3A SG149695A1 (en) 2002-02-18 2003-02-17 Chemical compounds
MXPA04007906A MXPA04007906A (es) 2002-02-18 2003-02-17 Compuestos quimicos.
AU2003206554A AU2003206554B2 (en) 2002-02-18 2003-02-17 Chemical compounds
EP03705600A EP1478624B1 (en) 2002-02-18 2003-02-17 Chemical compounds
JP2003567874A JP4435571B2 (ja) 2002-02-18 2003-02-17 化学化合物
DE60334074T DE60334074D1 (de) 2002-02-18 2003-02-17 Chemische verbindung
NZ534296A NZ534296A (en) 2002-02-18 2003-02-17 Chemical compounds
ARP030100530A AR038566A1 (es) 2002-02-18 2003-02-18 Compuestos quimicos derivados de piperidina, un proceso para su preparacion y una composicion farmaceutica que lo comprende
IS7381A IS7381A (is) 2002-02-18 2004-08-03 Efnasambönd
CO04078830A CO5611135A2 (es) 2002-02-18 2004-08-12 Nuevos derivados de piperidina como moduladores de la actividad de quimioquina, procesos para su preparacion y composiciones farmaceuticas que los contienen
NO20043899A NO20043899L (no) 2002-02-18 2004-09-17 Kjemiske forbindelser
RU2007146928/04A RU2007146928A (ru) 2002-02-18 2007-12-20 Химические соединения
IL195011A IL195011A0 (en) 2002-02-18 2008-10-30 Process for preparing piperidine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202673A SE0202673D0 (sv) 2002-09-09 2002-09-09 Chemical compounds

Publications (1)

Publication Number Publication Date
SE0202673D0 true SE0202673D0 (sv) 2002-09-09

Family

ID=20288944

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202673A SE0202673D0 (sv) 2002-02-18 2002-09-09 Chemical compounds

Country Status (2)

Country Link
SE (1) SE0202673D0 (sv)
UA (1) UA80268C2 (sv)

Also Published As

Publication number Publication date
UA80268C2 (en) 2007-09-10

Similar Documents

Publication Publication Date Title
MXPA03011722A (es) Derivados de piperidina utiles como moduladores de actividad de quimiocina.
SG146658A1 (en) Haloalkyl containing compounds as cysteine protease inhibitors
DE60315323D1 (de) Piperidinderivate zur verwendung bei der behandlung von durch chemokins vermittelten leiden
CA2425557A1 (en) Anticholinergic agents that can be used as medicaments and method for the production thereof
ATE406353T1 (de) Piperidin-derivaten und deren verwendung bei der behandlung von durch chemokinen oder h1 vermittelten krankheiten
CO5611135A2 (es) Nuevos derivados de piperidina como moduladores de la actividad de quimioquina, procesos para su preparacion y composiciones farmaceuticas que los contienen
AR034268A1 (es) Compuestos derivados de piperidina, su uso en preparacion de medicamentos, composicion farmaceutica, metodo de tratamiento y proceso para su preparacion
YU79502A (sh) Novi,sporodelujući betamimetici,postupak za njihovo pripremanje i njihova primena kao lekova
NO20061126L (no) Aminopyroner og deres anvendelse som ATM-inhibitorer
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
CA2121253A1 (en) Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
ATE527259T1 (de) Kondensierte aminopiperidine als dipeptidylpeptidase-iv-inhibitoren zur behandlung oder prävention von diabetes
DE60322877D1 (de) Tetrahydropyranylcyclopentyltetrahydroisochino-linmodulatoren der chemokinrezeptoraktivität
PE20050867A1 (es) DERIVADOS DE PIPERAZINA COMO INHIBIDORES DE LA INTERACCION DE gp 120 CON CD4
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
BR0312882A (pt) Derivados de pleuromutilina como antimicrobianos
BRPI0406835A (pt) Derivados de triazina como absorvedores de uv
DE60213625D1 (de) Piperidinderivate und deren verwendung als modulatoren der chemokinaktivität (insbesondere der von ccr3)
BRPI0113837B8 (pt) compostos mutilinas com atividade antimicrobiana e composição farmacêutica que os compreende
SE0200844D0 (sv) Chemical compounds
NZ524742A (en) Bridged piperazine derivatives
ATE397599T1 (de) Als modulatoren der chemokinrezeptoraktivität geeignete piperidinderivate
PE20040750A1 (es) Derivados de n-(1-acetilpiperidin-4-il)-4-benzidril-2-isopropilpiperazin-1-carboxamida como inhibidores de 17beta-hidroxiesteroide deshidrogenasa de tipo 3